[go: up one dir, main page]

NO20093384L - Sykdomsmarkorer - Google Patents

Sykdomsmarkorer

Info

Publication number
NO20093384L
NO20093384L NO20093384A NO20093384A NO20093384L NO 20093384 L NO20093384 L NO 20093384L NO 20093384 A NO20093384 A NO 20093384A NO 20093384 A NO20093384 A NO 20093384A NO 20093384 L NO20093384 L NO 20093384L
Authority
NO
Norway
Prior art keywords
autoimmune disease
sykdomsmarkorer
biomarkers
cytokine
kits
Prior art date
Application number
NO20093384A
Other languages
English (en)
Inventor
David Wraith
Heather Streeter
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Publication of NO20093384L publication Critical patent/NO20093384L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Den foreliggende oppfinnelse vedrører biomarkører for autoimmun sykdom og vedrører spesielt en fremgangsmåte for å bestemme en status til en autoimmun sykdom i et testindivid, som omfatter å måle produksjon av et Th2 cytokin ved hjelp av leukocytter fra individet, så vel som assosierte anvendelser og kit.
NO20093384A 2007-04-24 2009-11-19 Sykdomsmarkorer NO20093384L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0707933.8A GB0707933D0 (en) 2007-04-24 2007-04-24 Disease markers
PCT/GB2008/001415 WO2008129296A2 (en) 2007-04-24 2008-04-23 Disease markers

Publications (1)

Publication Number Publication Date
NO20093384L true NO20093384L (no) 2010-01-18

Family

ID=38135366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20093384A NO20093384L (no) 2007-04-24 2009-11-19 Sykdomsmarkorer

Country Status (13)

Country Link
US (1) US20100129853A1 (no)
EP (1) EP2156190A2 (no)
JP (1) JP2010525355A (no)
CN (1) CN102317787A (no)
AU (1) AU2008240367A1 (no)
BR (1) BRPI0810559A2 (no)
CA (1) CA2685113A1 (no)
GB (1) GB0707933D0 (no)
MX (1) MX2009011494A (no)
NO (1) NO20093384L (no)
PL (1) PL391035A1 (no)
RU (1) RU2009142935A (no)
WO (1) WO2008129296A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
EP2240781B1 (en) 2008-01-18 2018-01-10 President and Fellows of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
GB0903391D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Biomarkers
US20130071860A1 (en) * 2010-02-24 2013-03-21 Matthew B. Hale Methods for autoimmune disease diagnosis, prognosis, and treatment`
CA2806291C (en) 2010-07-23 2023-08-29 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
EP2596353A4 (en) 2010-07-23 2014-01-15 Harvard College METHOD FOR DETECTING PRENATAL OR PREGNANT DISEASES OR SUFFERING
CA2806310A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
EP4202441A3 (en) 2013-03-09 2023-07-26 Immunis.AI, Inc. Gene expression profile in macrophages for the diagnosis of cancer
GB201400562D0 (en) 2014-01-14 2014-03-05 Orla Protein Technologies Ltd Protein coated polymeric substrate
AU2015314813B2 (en) 2014-09-11 2022-02-24 Immunis.Ai, Inc. Methods of detecting prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL214283B1 (pl) * 2002-08-08 2013-07-31 Baylor College Medicine Sposób izolacji komórek T, sposób wytwarzania autologicznej szczepionki komórek T, autologiczna szczepionka komórek T, zastosowanie autologicznej szczepionki komórek T
EP2287616A1 (en) * 2003-09-15 2011-02-23 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate systemic lupus erythematosus

Also Published As

Publication number Publication date
RU2009142935A (ru) 2011-05-27
US20100129853A1 (en) 2010-05-27
CA2685113A1 (en) 2008-10-30
PL391035A1 (pl) 2010-10-25
BRPI0810559A2 (pt) 2015-02-10
JP2010525355A (ja) 2010-07-22
WO2008129296A2 (en) 2008-10-30
EP2156190A2 (en) 2010-02-24
AU2008240367A1 (en) 2008-10-30
GB0707933D0 (en) 2007-05-30
MX2009011494A (es) 2009-11-09
CN102317787A (zh) 2012-01-11
WO2008129296A3 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
NO20093384L (no) Sykdomsmarkorer
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
WO2007062090A8 (en) Methods and compositions related to b cell assays
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
GB2474146A (en) Methods of determining the health status of an individual
IL251791B (en) Biomarker for ovarian cancer: ctap3-related proteins
MX2010005893A (es) Marcadores de expresion genica para enfermedad inflamatoria de intestino.
WO2011038155A3 (en) Genetic analysis
NO20084059L (no) Fremgangsmate og apparat for a konstruere og anvende et referanseverktoy for a generere et differensierende signal for indikasjon av en medisinsk tilstand hos et individ
WO2006074430A3 (en) Biomarkers for melanoma
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
DK2449370T3 (da) Analyse og test af glykerede hæmoglobiner ved kapillær elektroforese, buffersammensætninger og sæt til kapillær elektroforese
WO2010068686A3 (en) Methods of diagnosing and predicting renal disease
DK1974210T3 (da) Fremgangsmåde til diagnosticering af polycystisk nyresygdom
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
WO2010107816A3 (en) Nucleic acid binding dyes and uses therefor
RU2011116763A (ru) Способ количественного определения термического стресса, которому подвергался фруктовый сок
NO20073680L (no) Fremgangsmate for a analysere data som har felles og saerskilte egenskaper
GB201305388D0 (en) Benchmarks for normal cell identification
NO20073508L (no) Anordninger og fremgangsmåter for formasjonstesting ved trykkmåling i et isolert, variabelt volum
WO2010087594A3 (ko) 시디９３ 또는 이의 가용성 단편의 용도
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
MX2013004230A (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
WO2008153543A3 (en) Fluorescent mouse model

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application